Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,202 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06621121Recruiting
Comparing two clot-busting drugs for stroke within 4.5 hours
This study compares two medications, tenecteplase and alteplase, to see which works better at dissolving blood clots in people having an ischemic stroke. You may join if you can get treatment within 4.5 hours of when your symptoms started.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06661642Recruiting
Predicting pain after planned surgery
This study looks at whether we can predict how much pain you will feel after surgery. It aims to help doctors better manage pain after your operation.
AalborgAges 18 years+ - NCT06661967Recruiting
Numbing gel for breathing tube insertion in emergencies
This trial tests if adding a numbing gel to standard care helps doctors insert a breathing tube more quickly on the first try. If you need a breathing tube in the emergency room and are over 18, you may be able to join.
Chon Buri, Changwat Chon BuriAges 18 years+ - NCT06176027RecruitingPhase 1/Phase 2
New drug combo for returning AITL lymphoma
This trial tests a new combination of drugs (azacytidine plus CAOLD) for people with a specific type of T-cell lymphoma called AITL that has come back or not responded to previous treatment. The goal is to see if this treatment can work better than current options.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06598202RecruitingPhase 1/Phase 2
Nasal Drop Therapy for ALS
This trial tests a nasal drop made from tiny cell particles (extracellular vesicles) for ALS. The goal is to see if it's safe and if it can slow down the disease. It may be an option if your ALS is in the early to moderate stage.
Beijing, Beijing MunicipalityAges 18–80 - NCT06641856Recruiting
Healthy volunteers study in Shanghai
This study looks at the viruses living in the respiratory tract of healthy people in Shanghai. It will help doctors understand how our immune system protects us.
Shanghai, Shanghai MunicipalityAges 20–75 - NCT06663007RecruitingPhase 1/Phase 2
RC48 alone or with envafolimab for advanced prostate cancer with CDK12 changes
This trial tests a drug called RC48, alone or with envafolimab, for men with a specific type of advanced prostate cancer that has not responded to standard treatments. It aims to see if this combination can shrink tumors or slow disease progression.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06663267Recruiting
Weather and air pollution effects on heart health
This trial looks at how weather and air pollution may impact your heart health. It uses medical records to study these effects.
Hanzhou, ZhejiangAges 18–75 - NCT06663059RecruitingPhase 2
Adebrelimab before surgery for esophageal cancer: 2 vs 4 cycles
This trial tests a drug called Adebrelimab (an immunotherapy) given before surgery to treat esophageal squamous cell cancer. It compares 2 cycles of treatment with 4 cycles to see which works better. The goal is to shrink the tumor and make surgery more effective.
Xi'an, ShannxiAges 18–75 - NCT05929729RecruitingPhase 4
Brain study in women with iron deficiency anemia
This is a study that looks at how iron deficiency anemia may affect the brain, and it also checks whether giving iron through an IV is safe and helpful for some participants. You may be in an observation-only group or an iron-treatment group, depending on study testing.
Duarte, CaliforniaAges 16–60 - NCT06663111Recruiting
Rituximab and Ocrelizumab levels in Multiple Sclerosis
This trial looks at two medicines, rituximab and ocrelizumab, in the blood of people with multiple sclerosis. It only includes people who are already in another study called OVERLORD-MS and can give blood samples on a schedule.
Bergen, VestlandAges 18–60 - NCT06288373RecruitingPhase 2/Phase 3
Comparing chemoimmunotherapy vs chemoradiation for advanced cervical cancer before surgery
This trial tests whether a combination of chemotherapy and immunotherapy (pembrolizumab) before surgery works better than standard chemoradiation for locally advanced cervical cancer. It may help shrink tumors more effectively.
Hefei, AnhuiAges 18–70 - NCT04561557RecruitingEarly Phase 1
Cell therapy for relapsing nervous system autoimmune diseases
This early-phase trial tests CT103A “CAR-T” cell therapy to treat certain relapsing or treatment-resistant autoimmune diseases that affect the nervous system. It aims to see whether the cells are safe and may help reduce disease activity when standard treatments haven’t controlled symptoms.
Wuhan, HubeiAges 18–75 - NCT05961306Recruiting
Testing a stepped screening plan during pregnancy and after birth
This study checks how well a step-by-step screening approach and its tools work for identifying issues during pregnancy (weeks 20–24) or in early postpartum (6–10 weeks after delivery). It may help doctors use more accurate screening to decide who needs further care.
Ghent, Oost-VlaanderenAges 18 years+ - NCT05326828Recruiting
Implant monitor to find hidden atrial fibrillation after heart injury
This study tests whether an implantable heart rhythm monitor can detect atrial fibrillation (an irregular heartbeat) in people who had a type of heart attack with non-obstructed arteries. The goal is to find a possible reason for the event so doctors can treat it appropriately.
BernAges 18–85 - NCT06664996RecruitingPhase 2
Immunotherapy plus radiation before surgery for liver cancer with portal vein tumor clot
This trial tests combining an immunotherapy drug (sintilimab) with focused radiation (SBRT) before surgery for liver cancer that has spread into a branch of the portal vein. The goal is to see if this combination can shrink the tumor and make surgery more successful.
Chengdu, SichuanAges 18 years+ - NCT06215989Recruiting
Low-dose colchicine for acute coronary syndrome
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06365710Recruiting
Physiotherapy vs telerehab after wrist fracture surgery
This study compares in-person physiotherapy with remote telerehabilitation after a specific type of wrist fracture surgery. It aims to see if doing rehab at home works as well as going to a clinic.
Helsinki, UusimaaAges 18–65 - NCT07677124Recruiting
AI analysis of skin images for basal cell carcinoma risk
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
Istanbul, IstanbulAges birth–100 years - NCT07678996Recruiting
Ozone injections for knee arthritis: finding the right dose
This study tests whether injecting ozone gas into the knee joint can reduce pain in people with knee osteoarthritis. It aims to find the best dose to help with pain during activities like walking.
KayseriAges 40–75 - NCT07679204Recruiting
Personality and life satisfaction in bipolar and depression
This study looks at how personality traits and life satisfaction affect people with bipolar II disorder or major depression. You will fill out questionnaires about your feelings and daily life.
ElâzığAges 18 years+ - NCT07678086Recruiting
Breathing tube pressure and sore throat in children's appendix surgery
This trial tests whether carefully managing the pressure in the breathing tube during surgery can help prevent a sore throat in children after they have their appendix removed by keyhole surgery. It may help your child have a more comfortable recovery.
Ankara, YenimahalleAges 6–18 - NCT07673913Recruiting
Blood markers and brain stimulation for hard-to-treat depression
This study is testing whether a new type of brain stimulation called intermittent theta burst stimulation (iTBS) can help people with treatment-resistant depression (depression that hasn't improved with standard medicines). It also looks at certain blood markers to see if they can predict how well someone will respond to this treatment.
Ankara, AnkaraAges 18–55 - NCT07675395Enrolling by invitation
Heart remodeling after pulsed field ablation for persistent atrial fibrillation
This study looks at how a new type of heart procedure, called pulsed field ablation, affects the heart's structure in people with persistent atrial fibrillation. It may help doctors understand if this treatment improves heart function over time.
TaipeiAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,202 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.